In various cancers, aberrant STAT5 signaling increases the expression of target genes, such as cyclin D, Bcl-2, and MMP-2, eventually resulting in the promotion of cell proliferation, survival, and metastasis [46]. This evidence concerns the gene BCL2 and cancer.